Detalhe da pesquisa
1.
Osimertinib in advanced EGFR-T790M mutation-positive non-small cell lung cancer patients treated within the Special Use Medication Program in Spain: OSIREX-Spanish Lung Cancer Group.
BMC Cancer
; 21(1): 230, 2021 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33676426
2.
Long-term Clinical Outcomes of a Spanish Cohort of Metastatic Renal Cell Carcinoma Patients with a Complete Response to Sunitinib.
Clin Genitourin Cancer
; 21(3): e166-e174, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36610891
3.
A primary signet ring cell carcinoma of the prostate with bone metastasis with impressive response to FOLFOX and cetuximab.
Clin Genitourin Cancer
; 10(3): 199-201, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22409863